Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin for Prevention of Acute Kidney Injury in Cirrhotic Patients with Upper Gastrointestinal Bleeding
NCT04358016Phase 4Completed
- Sponsor
- Changhai Hospital
- Start
- Jan 2018
- Primary completion
- Jan 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of terlipressin in acute kidney injury (AKI), sponsored by Changhai Hospital. Started Jan 2018; status: completed.
02
Drugs
terlipressin
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT04358016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04358016.